Avantor (AVTR)

$15.19 -1.59% on the day Market cap $10.4B 52-week range $7.26 to $16.38 Prices as of Oct 7, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
6% a year for 10 years

At a market value of $10.4B, Avantor's free cash flow of $495M (fiscal 2025) would need to grow about 6% a year for the stock to be worth today's price. That is slower than the company has grown its free cash flow over the last 7 years.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Avantor's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price5.6% a year
Free cash flow, last 7 years17.2% a year
Revenue, same period23.0% a year
Price to free cash flow20.9x

Fundamental grade

D

Five factors scored 1 to 9 from AVTR's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation7
Profitability1
Growth0
Financial health4
Cash efficiency4

Key numbers

P/E (trailing)—
P/E (forward)—
Price / free cash flow—
EV / EBITDA—
Price / sales1.58x
Price / book—
Revenue growth+0.0%
Operating margin-4.5%
Net margin-8.4%
Return on equity-9.9%
Dividend yield—
Debt / equity1.09x

Results from SEC filings

Fiscal years, from Avantor's 10-K filings. The deep dive has 15+ years, quarters and every line.

Fiscal year20212022202320242025
Revenue$7.4B$7.5B$7.0B$6.8B$6.6B
Net income$573M$686M$321M$712M-$530M
Free cash flow$842M$710M$724M$692M$495M
EPS (diluted)$0.85$1.01$0.47$1.04-$0.78
Operating margin13.2%15.0%10.0%16.0%-3.8%

Where the revenue comes from

Revenue by segments, fiscal 2025.

Laboratory Solutions$4.4B67%
Bioscience Production$2.2B33%

Superinvestors who own AVTR

From each investor's latest 13F filing (what a 13F shows). 9 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Dodge & Cox
Dodge & Cox
Added $1.2B0.62%Q2 2026
Ed Wachenheim
Greenhaven Associates
Added $244M2.8%Q2 2026
Cliff Asness
AQR Capital Management
Added $115M0.04%Q2 2026
Steven Romick
First Pacific Advisors
Added $81M1.0%Q2 2026
Donald Yacktman
Yacktman Asset Management
Added $47M0.58%Q2 2026
Mason Hawkins
Southeastern Asset Management
Added $47M2.4%Q2 2026
Joel Greenblatt
Gotham Asset Management
Added $25M0.06%Q2 2026
Ric Dillon
Diamond Hill Capital Management
Trimmed $10M0.08%Q2 2026
Hersh Cohen
ClearBridge Investments
New position $131,4130.0%Q2 2026

Insider buying

Open-market purchases by Avantor's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of AVTR in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when AVTR trades at or below it.

$

Free accounts get 3 price alerts. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does Avantor's stock price imply?

At a market value of $10.4B, Avantor would need its free cash flow to grow about 6% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 7 years its free cash flow grew 17% a year.

Are Avantor insiders buying the stock?

No open-market insider purchases of AVTR in the last 12 months, according to SEC Form 4 filings.

Which superinvestors own Avantor?

9 of the superinvestors Investingly tracks hold AVTR in their latest 13F, including Dodge & Cox, Ed Wachenheim, Cliff Asness.

Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.